Wedmont Private Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Sell
3,499
-405
-10% -$112K 0.02% 394
2026
Q1
$1.18M Buy
3,904
+250
+7% +$74.3K 0.04% 275
2025
Q4
$975K Buy
3,654
+155
+4% +$42.1K 0.03% 294
2025
Q3
$922K Sell
3,499
-99
-3% -$26.9K 0.03% 292
2025
Q2
$992K Buy
3,598
+400
+13% +$109K 0.04% 263
2025
Q1
$836K Buy
3,198
+398
+14% +$98.2K 0.04% 255
2024
Q4
$642K Buy
2,800
+288
+11% +$66.2K 0.03% 304
2024
Q3
$557K Buy
2,512
+152
+6% +$31.5K 0.03% 324
2024
Q2
$456K Buy
2,360
+86
+4% +$17.8K 0.03% 367
2024
Q1
$477K Sell
2,274
-140
-6% -$29.4K 0.03% 328
2023
Q4
$483K Buy
2,414
+243
+11% +$51.8K 0.04% 318
2023
Q3
$468K Buy
2,171
+174
+9% +$34.6K 0.05% 268
2023
Q2
$372K Sell
1,997
-115
-5% -$21.3K 0.04% 325
2023
Q1
$407K Buy
+2,112
New +$382K 0.05% 260
2022
Q2
Sell
-1,372
Closed -$322K 344
2022
Q1
$322K Buy
+1,372
New +$322K 0.07% 221

Other funds holding CME

Wedmont Private Capital's CME Position: Q2 2026 in Review

Wedmont Private Capital reduced its CME Group (CME) stake by 10% in Q2 2026, selling an estimated $112K and leaving 3,499 shares worth $841K. The position accounts for 0.02% of the portfolio, ranked #394.

Wedmont Private Capital first reported a position in CME in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.18M in Q1 2026. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Wedmont Private Capital held 3,499 shares of CME Group worth $841K as of Q2 2026.
  • Wedmont Private Capital sold 405 CME Group shares in Q2 2026, an estimated $112K.
  • CME Group made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #394 holding.
  • Wedmont Private Capital first reported a position in CME Group in Q1 2022 and has held it in 15 quarters since.
  • Wedmont Private Capital's CME Group position peaked at $1.18M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.